These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 36688961)
41. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis. Bae DG; Kim TD; Li G; Yoon WH; Chae CB Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646 [TBL] [Abstract][Full Text] [Related]
42. Antiangiogenic activity of ursolic acid. Kanjoormana M; Kuttan G Integr Cancer Ther; 2010 Jun; 9(2):224-35. PubMed ID: 20462855 [TBL] [Abstract][Full Text] [Related]
43. alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. Belleri M; Ribatti D; Savio M; Stivala LA; Forti L; Tanghetti E; Alessi P; Coltrini D; Bugatti A; Mitola S; Nicoli S; Vannini V; Presta M Mol Cancer Ther; 2008 Dec; 7(12):3761-70. PubMed ID: 19074851 [TBL] [Abstract][Full Text] [Related]
44. Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate. Thejass P; Kuttan G Integr Cancer Ther; 2007 Dec; 6(4):389-99. PubMed ID: 18048887 [TBL] [Abstract][Full Text] [Related]
45. Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion. Zhang LJ; Chen L; Lu Y; Wu JM; Xu B; Sun ZG; Zheng SZ; Wang AY Eur J Pharmacol; 2010 Sep; 643(2-3):195-201. PubMed ID: 20621088 [TBL] [Abstract][Full Text] [Related]
46. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis. Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688 [TBL] [Abstract][Full Text] [Related]
47. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts. Rofstad EK; Halsør EF Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309 [TBL] [Abstract][Full Text] [Related]
48. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways. Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904 [TBL] [Abstract][Full Text] [Related]
49. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling. Hasumi Y; Kłosowska-Wardega A; Furuhashi M; Ostman A; Heldin CH; Hellberg C Int J Cancer; 2007 Dec; 121(12):2606-14. PubMed ID: 17691110 [TBL] [Abstract][Full Text] [Related]
50. Placental growth factor upregulation is a host response to antiangiogenic therapy. Bagley RG; Ren Y; Weber W; Yao M; Kurtzberg L; Pinckney J; Bangari D; Nguyen C; Brondyk W; Kaplan J; Teicher BA Clin Cancer Res; 2011 Mar; 17(5):976-88. PubMed ID: 21343374 [TBL] [Abstract][Full Text] [Related]
51. Antitumor effect of a pyrazolone-based-complex [Cu(PMPP-SAL)(EtOH)] against murine melanoma B16 cell in vitro and in vivo. Abula A; Zhao J; Xu G; Li Y; Sun S Acta Pharm; 2020 Dec; 70(4):561-575. PubMed ID: 32412431 [TBL] [Abstract][Full Text] [Related]
52. Vernolide-A inhibits radiation-induced hypoxia-mediated tumor angiogenesis by regulating HIF-1α, MMP-2, MMP-9, and VEGF. Pratheeshkumar P; Kuttan G J Environ Pathol Toxicol Oncol; 2011; 30(2):139-51. PubMed ID: 21967458 [TBL] [Abstract][Full Text] [Related]
53. Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents. Zhang G; Dass CR; Sumithran E; Di Girolamo N; Sun LQ; Khachigian LM J Natl Cancer Inst; 2004 May; 96(9):683-96. PubMed ID: 15126605 [TBL] [Abstract][Full Text] [Related]
54. Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation. Quan L; Ohgaki R; Hara S; Okuda S; Wei L; Okanishi H; Nagamori S; Endou H; Kanai Y J Exp Clin Cancer Res; 2020 Nov; 39(1):266. PubMed ID: 33256804 [TBL] [Abstract][Full Text] [Related]
55. Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor. Chen L; Lu Y; Wu JM; Xu B; Zhang LJ; Gao M; Zheng SZ; Wang AY; Zhang CB; Zhang WW; Lei N Biochem Biophys Res Commun; 2009 Aug; 386(2):374-9. PubMed ID: 19523924 [TBL] [Abstract][Full Text] [Related]
56. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor. Zhao Y; Adjei AA Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391 [TBL] [Abstract][Full Text] [Related]
58. VEGF/Flk1 Mechanism is Involved in Roxarsone Promotion of Rat Endothelial Cell Growth and B16F10 Xenograft Tumor Angiogenesis. Chen S; Xu J; Wei Q; Zhao Z; Chen X; Cui H; Zhang Y Sci Rep; 2019 Nov; 9(1):17417. PubMed ID: 31758020 [TBL] [Abstract][Full Text] [Related]
59. Saikosaponin b2 inhibits tumor angiogenesis in liver cancer via down‑regulation of VEGF/ERK/HIF‑1α signaling. You M; Fu J; Lv X; Wang L; Wang H; Li R Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37232376 [TBL] [Abstract][Full Text] [Related]
60. Acidic mucopolysaccharide from Holothuria leucospilota has antitumor effect by inhibiting angiogenesis and tumor cell invasion in vivo and in vitro. Zhang W; Lu Y; Xu B; Wu J; Zhang L; Gao M; Zheng S; Wang A; Zhang C; Chen L; Lei N Cancer Biol Ther; 2009 Aug; 8(15):1489-99. PubMed ID: 19483477 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]